SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP EBITDA Margin

EBITDA as a percentage of revenue.

No reported EBITDA Margin figures are available to summarize.

EBITDA Margin history

Percent of revenue · from the income statement

No EBITDA Margin data reported for this period type.

EBITDA Margin vs competitors

How SGP compares with its peers on the latest reported figures

SGP Competitors Peer median
EBITDA Margin for SGP and competitors
Company Period LTM level YoY 3-year change
ALCAlcon Inc.LTM Sep 202625.4% -0.9 pp+4.0 pp
BLCOBausch + Lomb CorporationLTM Jun 202613.9% +4.5 pp-5.4 pp
STAASTAAR Surgical CompanyLTM Apr 2026-1.4% +10.6 pp-48.3 pp
GKOSGlaukos CorporationLTM Jun 2026-23.0% -12.0 pp-11.5 pp
RXSTRxSight, Inc.LTM Mar 2026-33.9% -19.3 pp+89.0 pp
SGHTSight Sciences, Inc.LTM Mar 2026-39.8% +16.3 pp+70.4 pp
OCULOcular Therapeutix, Inc.LTM Mar 2026-527.0% -231.3 pp-361.8 pp
EYPTEyePoint Pharmaceuticals, Inc.LTM Mar 2026-3415.1% -3156.5 pp-497.7 pp
OCSOculis Holding AGLTM Mar 2026-18676.3% ——
SGPSpyGlass Pharma, Inc. Common StockFY2025— ——
Peer median (excluding SGP) -33.9%-6.4 pp-8.5 pp

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.